These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36387508)
1. Corrigendum to "Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment" [Heliyon 8 (9) (2022) e10694]. Ruswanto R; Nofianti T; Mardianingrum R; Kesuma D; Siswandono Heliyon; 2022 Nov; 8(11):e11273. PubMed ID: 36387508 [TBL] [Abstract][Full Text] [Related]
2. Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment. Ruswanto R; Nofianti T; Mardianingrum R; Kesuma D; Siswandono Heliyon; 2022 Sep; 8(9):e10694. PubMed ID: 36177227 [TBL] [Abstract][Full Text] [Related]
3. Corrigendum to "Discovery of small molecules through pharmacophore modeling, docking and molecular dynamics simulation against Plasmodium vivax Vivapain-3 (VP-3)" [Heliyon 4(5), May 2018, Article e00612]. Saddala MS; Adi PJ Heliyon; 2024 May; 10(9):e30425. PubMed ID: 38807609 [TBL] [Abstract][Full Text] [Related]
4. Corrigendum to "Prediction of methane diffusion coefficient in water using molecular dynamics simulation" [Heliyon 6 (11) (November 2020) e05385]. Moradi H; Azizpour H; Bahmanyar H; Mohammadi M; Akbari M Heliyon; 2021 Jul; 7(7):e07488. PubMed ID: 34307939 [TBL] [Abstract][Full Text] [Related]
5. Corrigendum to 'Vibrational spectra, Hirshfeld surface analysis, molecular docking studies of (RS)-N,N-bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide by DFT approach'[Heliyon, 6(2020) 4641]. Govindammal M; Prasath M Heliyon; 2024 Feb; 10(4):e26325. PubMed ID: 38495530 [TBL] [Abstract][Full Text] [Related]
6. Corrigendum to "circAR-E2E4-miR-665-STAT3 axis is a potential regulatory network in triple-negative breast cancer" [Heliyon 9(1), January 2023, Article e12654]. Xu H; Fang M; Ye S; Zuo B; Yao W; Ren J; Zhang Y Heliyon; 2023 May; 9(5):e15215. PubMed ID: 37305463 [TBL] [Abstract][Full Text] [Related]
7. Corrigendum to "Annexin 2 protein expression is associated with breast cancer subtypes in African American women" [Heliyon Volume 6, Issue 2, February 2020, e03241]. Beyene DA; Kanarek NF; Naab TJ; Ricks-Santi LL; Hudson TS Heliyon; 2020 Mar; 6(3):e03467. PubMed ID: 32258448 [TBL] [Abstract][Full Text] [Related]
8. Corrigendum to "The cardiotoxicity effect of different chemotherapeutic regimens in Iraqi patients with breast cancer: A follow up study" [Heliyon 5 (8) (August 2019) e02194]. Anber ZNH; Saleh BOM; Al-Rawi SA Heliyon; 2020 Feb; 6(2):e03398. PubMed ID: 32095649 [TBL] [Abstract][Full Text] [Related]
9. Corrigendum to "Gunshot-wound dynamics model for John F. Kennedy assassination" [Heliyon 4 (2018) e00603]. Nalli NR Heliyon; 2018 Oct; 4(10):e00831. PubMed ID: 30294686 [TBL] [Abstract][Full Text] [Related]
10. Corrigendum to "Towards identifying enablers and inhibitors to on-farm entrepreneurship: Evidence from smallholders in KwaZulu-Natal, South Africa" [Heliyon 7 (1) (January 2021) Article e05660]. Wale E; Chipfupa U; Hadebe N Heliyon; 2021 Mar; 7(3):e06376. PubMed ID: 33732927 [TBL] [Abstract][Full Text] [Related]
11. Corrigendum to "The current land use dynamics are dependent on the previous land conversion legacies in farming system of west Oromia, Ethiopia" [Heliyon 8 (12) (December 2022) e12504]. Enkossa T; Nemomissa S; Lemessa D Heliyon; 2023 Mar; 9(3):e13953. PubMed ID: 37101484 [TBL] [Abstract][Full Text] [Related]
12. Corrigendum to "A comprehensive review on modelling the adsorption process for heavy metal removal from waste water using artificial neural network technique" [Heliyon 9(4) (April 2023) e15455]. Fiyadh SS; Alardhi SM; Al Omar M; Aljumaily MM; Al Saadi MA; Fayaed SS; Ahmed SN; Salman AD; Abdalsalm AH; Jabbar NM; El-Shafi A Heliyon; 2023 Jul; 9(7):e17675. PubMed ID: 37539279 [TBL] [Abstract][Full Text] [Related]
13. Corrigendum to "Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy" [Heliyon 4 (12) (December 2018) e01039]. Wu X; Li Y; Liu X; Chen C; Harrington SM; Cao S; Xie T; Pham T; Mansfield AS; Yan Y; Kwon ED; Wang L; Ling K; Dong H Heliyon; 2019 Mar; 5(3):e01309. PubMed ID: 30937406 [TBL] [Abstract][Full Text] [Related]
14. Corrigendum to "Fluoxetine combined with risperidone in treatment of online gambling disorder-case report" [Heliyon 9 (3) (March 2023) Article e13772]. Bai M; Huang E; Du H; Yang L; Zhang X; Yang Y; Yan Z; Wang W Heliyon; 2023 May; 9(5):e15509. PubMed ID: 37305480 [TBL] [Abstract][Full Text] [Related]
15. Corrigendum to "Multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds" [Heliyon 8 (9), (September 2022) e09616]. Li R; Zhou W Heliyon; 2022 Nov; 8(11):e11558. PubMed ID: 36419666 [TBL] [Abstract][Full Text] [Related]
16. Corrigendum to "Repeated hypocalcemia in a patient with "Hikikomori" following veganism" [Heliyon 8 (6), (July 2022), Article e09563]. Suzuki K; Miyamoto K; Ozawa S; Kawakami R; Nakamura M; Inoue G; Kato A; Tarumi Y; Yagi M; Dohi K Heliyon; 2022 Aug; 8(8):e10020. PubMed ID: 35991995 [TBL] [Abstract][Full Text] [Related]
17. Corrigendum to "Atrase A, a P-III class metalloproteinase purified from cobra venom, exhibits potent anticoagulant activity by inhibiting coagulation pathway and activating the fibrinolytic system" [Heliyon Volume 10, Issue 10, 30 May 2024, Article e30969]. Zhong XJ; Wang CE; Li YN; Zhang QY; Sun QY Heliyon; 2024 Jul; 10(13):e33331. PubMed ID: 39185499 [TBL] [Abstract][Full Text] [Related]